Literature DB >> 30298434

Tissue Physiology of Cynomolgus Monkeys: Cross-Species Comparison and Implications for Translational Pharmacology.

Danielle Mandikian1, Isabel Figueroa1, Amy Oldendorp2, Hanine Rafidi1, Sheila Ulufatu2, Michelle G Schweiger2, Jessica A Couch2, Noel Dybdal2, Sean B Joseph1, Saileta Prabhu1, Gregory Z Ferl3,4, C Andrew Boswell5,6.   

Abstract

We previously performed a comparative assessment of tissue-level vascular physiological parameters in mice and rats, two of the most commonly utilized species in translational drug development. The present work extends this effort to non-human primates by measuring tissue- and organ-level vascular volumes (Vv), interstitial volumes (Vi), and blood flow rates (Q) in cynomolgus monkeys. These measurements were accomplished by red blood cell labeling, extracellular marker infusion, and rubidium chloride bolus distribution, respectively, the same methods used in previous rodent measurements. In addition, whole-body blood volumes (BV) were determined across species. The results demonstrate that Vv, Vi, and Q, measured using our methods scale approximately by body weight across mouse, rat, and monkey in the tissues considered here, where allometric analysis allowed extrapolation to human parameters. Significant differences were observed between the values determined in this study and those reported in the literature, including Vv in muscle, brain, and skin and Q in muscle, adipose, heart, thymus, and spleen. The impact of these differences for selected tissues was evaluated via sensitivity analysis using a physiologically based pharmacokinetic model. The blood-brain barrier in monkeys was shown to be more impervious to an infused radioactive tracer, indium-111-pentetate, than in mice or rats. The body weight-normalized total BV measured in monkey agreed well with previously measured value in rats but was lower than that in mice. These findings have important implications for the common practice of scaling physiological parameters from rodents to primates in translational pharmacology.

Entities:  

Keywords:  allometric scaling; non-human primates; physiologically based pharmacokinetic modeling; tissue physiological parameters; translational pharmacology

Mesh:

Substances:

Year:  2018        PMID: 30298434     DOI: 10.1208/s12248-018-0264-z

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  76 in total

1.  Brain uptake kinetics of nicotine and cotinine after chronic nicotine exposure.

Authors:  P R Lockman; G McAfee; W J Geldenhuys; C J Van der Schyf; T J Abbruscato; D D Allen
Journal:  J Pharmacol Exp Ther       Date:  2005-04-21       Impact factor: 4.030

2.  Indirect indicator of transport stress in hematological values in newly acquired cynomolgus monkeys.

Authors:  Choong-Yong Kim; Jin Soo Han; Teruo Suzuki; Sang-Seop Han
Journal:  J Med Primatol       Date:  2005-08       Impact factor: 0.667

3.  A therapeutic antibody targeting BACE1 inhibits amyloid-β production in vivo.

Authors:  Jasvinder K Atwal; Yongmei Chen; Cecilia Chiu; Deborah L Mortensen; William J Meilandt; Yichin Liu; Christopher E Heise; Kwame Hoyte; Wilman Luk; Yanmei Lu; Kun Peng; Ping Wu; Lionel Rouge; Yingnan Zhang; Robert A Lazarus; Kimberly Scearce-Levie; Weiru Wang; Yan Wu; Marc Tessier-Lavigne; Ryan J Watts
Journal:  Sci Transl Med       Date:  2011-05-25       Impact factor: 17.956

4.  99mTc-HMPAO as a tumour blood flow agent.

Authors:  P A Hammersley; V R McCready; J W Babich; G Coghlan
Journal:  Eur J Nucl Med       Date:  1987

5.  The significance of the total-body hematocrit in measurements of blood compartments.

Authors:  K A Kirsch; R F Johnson; R J Gorten
Journal:  J Nucl Med       Date:  1971-01       Impact factor: 10.057

Review 6.  Interstitial-lymphatic mechanisms in the control of extracellular fluid volume.

Authors:  K Aukland; R K Reed
Journal:  Physiol Rev       Date:  1993-01       Impact factor: 37.312

7.  P-glycoprotein and mutlidrug resistance-associated proteins limit the brain uptake of saquinavir in mice.

Authors:  Seonghee Park; Patrick J Sinko
Journal:  J Pharmacol Exp Ther       Date:  2004-11-04       Impact factor: 4.030

8.  Effects of anti-VEGF on pharmacokinetics, biodistribution, and tumor penetration of trastuzumab in a preclinical breast cancer model.

Authors:  Cinthia V Pastuskovas; Eduardo E Mundo; Simon P Williams; Tapan K Nayak; Jason Ho; Sheila Ulufatu; Suzanna Clark; Sarajane Ross; Eric Cheng; Kathryn Parsons-Reponte; Gary Cain; Marjie Van Hoy; Nicholas Majidy; Sheila Bheddah; Josefa dela Cruz Chuh; Katherine R Kozak; Nicholas Lewin-Koh; Peter Nauka; Daniela Bumbaca; Mark Sliwkowski; Jay Tibbitts; Frank-Peter Theil; Paul J Fielder; Leslie A Khawli; C Andrew Boswell
Journal:  Mol Cancer Ther       Date:  2012-01-05       Impact factor: 6.261

9.  In vivo labeling of red blood cells with 99mTc: a new approach to blood pool visualization.

Authors:  D G Pavel; M Zimmer; V N Patterson
Journal:  J Nucl Med       Date:  1977-03       Impact factor: 10.057

10.  Studies on the exchange of fluids between host and tumor. III. Regulation of blood flow in hepatomas and other rat tumors.

Authors:  P M GULLINO; F H GRANTHAM
Journal:  J Natl Cancer Inst       Date:  1962-01       Impact factor: 13.506

View more
  8 in total

1.  Development of a Physiologically-Based Pharmacokinetic Model for Whole-Body Disposition of MMAE Containing Antibody-Drug Conjugate in Mice.

Authors:  Hsuan-Ping Chang; Zhe Li; Dhaval K Shah
Journal:  Pharm Res       Date:  2022-01-19       Impact factor: 4.200

2.  Whole-Body Pharmacokinetics of Antibody in Mice Determined using Enzyme-Linked Immunosorbent Assay and Derivation of Tissue Interstitial Concentrations.

Authors:  Hsuan-Ping Chang; Se Jin Kim; Dhaval K Shah
Journal:  J Pharm Sci       Date:  2020-06-02       Impact factor: 3.534

3.  AT-527, a Double Prodrug of a Guanosine Nucleotide Analog, Is a Potent Inhibitor of SARS-CoV-2 In Vitro and a Promising Oral Antiviral for Treatment of COVID-19.

Authors:  Steven S Good; Jonna Westover; Kie Hoon Jung; Xiao-Jian Zhou; Adel Moussa; Paolo La Colla; Gabriella Collu; Bruno Canard; Jean-Pierre Sommadossi
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

4.  Monitoring tumor cell death in murine tumor models using deuterium magnetic resonance spectroscopy and spectroscopic imaging.

Authors:  Friederike Hesse; Vencel Somai; Felix Kreis; Flaviu Bulat; Alan J Wright; Kevin M Brindle
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-23       Impact factor: 12.779

5.  Effect of molecular size on interstitial pharmacokinetics and tissue catabolism of antibodies.

Authors:  Hanine Rafidi; Sharmila Rajan; Konnie Urban; Whitney Shatz-Binder; Keliana Hui; Gregory Z Ferl; Amrita V Kamath; C Andrew Boswell
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 6.440

6.  Investigating brain uptake of a non-targeting monoclonal antibody after intravenous and intracerebroventricular administration.

Authors:  Arthur J Van De Vyver; Antje-Christine Walz; Mariette S Heins; Afsaneh Abdolzade-Bavil; Thomas E Kraft; Inja Waldhauer; Michael B Otteneder
Journal:  Front Pharmacol       Date:  2022-08-29       Impact factor: 5.988

7.  Mathematical Models of Blood-Brain Barrier Transport of Monoclonal Antibodies Targeting the Transferrin Receptor and the Insulin Receptor.

Authors:  William M Pardridge; Tom Chou
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-03

Review 8.  Kinetics of Blood-Brain Barrier Transport of Monoclonal Antibodies Targeting the Insulin Receptor and the Transferrin Receptor.

Authors:  William M Pardridge
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.